A looming ‘patent cliff’ could trigger a wave of biotech mergers and acquisitions, but innovation has also been humming along and could lift some stocks.
Related Posts
How to capitalize on the market fear and generate some income using options
Jeff Kilburg describes selling a put spread on the SPDR S&P 500 ETF Trust.
E.l.f. shares soar as cosmetics retailer raises guidance after posting 40% sales gain
E.l.f. Beauty raised its full year guidance after posting a 40% jump in sales.
GM raises 2024 earnings guidance after easily topping Wall Street’s third-quarter expectations
GM’s quarterly report comes just two weeks after an investor day in which the company indicated its earnings strength is expected to continue into next […]